Astrazeneca Plc (NQ: AZN )

51.39 +0.10 (+0.19%)

Streaming Delayed Price Updated: 1:13 PM EST, Jan 15, 2021 Add to My Watchlist

Price and Volume

Volume	4,648,660
Open	51.29
Bid (Size)	51.39 (5)
Ask (Size)	51.40 (15)
Prev. Close	51.29
Today's Range	51.15 - 51.55
52wk Range	48.17 - 58.08
Shares Outstanding	N/A
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News

AVEO Oncology Announces Results from Phase 1b Portion of DEDUCTIVE Study of Tivozanib (FOTIVDA®) in Combination with IMFINZI® (durvalumab) in Previously Untreated Metastatic Hepatocellular Carcinoma

Today 8:00 EST

AVEO Oncology (Nasdaq: AVEO) today announced the presentation of results from the Phase 1b portion of the Phase 1b/2 DEDUCTIVE clinical trial of tivozanib (FOTIVDA®), AVEO’s vascular endothelial growth...

Chi-Med Highlights Savolitinib Clinical Data to be Presented at Virtual WCLC

January 14, 2021

Performance

YTD	+1.72%	+1.72%
1 Month	+1.10%	+1.10%
3 Month	-2.21%	-2.21%
6 Month	-7.42%	-7.42%
1 Year	-7.42%	-7.42%

More News

Recombinetics Inc. Announces Neurofibromatosis Type 1 Research Collaboration with AstraZeneca

January 12, 2021

Are These The Best Biotech Stocks To Buy This Month?

January 12, 2021

AstraZeneca to Showcase Transformative Data Across Diverse Pipeline at World Conference on Lung Cancer

January 13, 2021

‘Lifeline to workers’: Why Biden’s call for a $1.9 billion COVID-19 rescue package has NOT come a moment too soon

January 14, 2021

Criminals come out of the woodwork as countries roll out COVID-19 vaccines

January 14, 2021

COVID-19 infection likely to provide immunity for at least 5 months, but people may still transmit virus, study finds

January 14, 2021

How Soon Could AstraZeneca's COVID Vaccine Be Available in the U.S.?

January 14, 2021

My Top 3 Large-Cap Stocks to Own in 2021

January 14, 2021

5 Large-Cap Stocks That'll Make You Richer in 2021

January 14, 2021

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.